Qingyuan Zhang

15PUBLICATIONS
34CO-AUTHORS
Haematological tumoursPredictive and prognostic markersAutoimmunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 29, 2026
HMGB1-Induced Metabolic Rewiring of Macrophages via RAGE/MAPK Fosters Endocrine Resistance in Breast Cancer.

|Jul 17, 2026
SOX5 Orchestrates Malignant Evolution via Promoter-Centric Chromatin Remodeling in MYC-Driven B-Cell Lymphoma.

|May 15, 2026
CCR7 orchestrates the malignant progression of memory B cells in MYC-overexpressing lymphoma.

|Mar 09, 2026
Spatial profiling uncovers multicellular dynamics in early relapse of hepatitis B virus-associated follicular lymphoma.

Yuwei Deng, Qingyuan Zhang, Zhenyuan Jia

|Dec 09, 2025
Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer.

Jianli Ma, Shengnan Sun, Xiaowen Tang

|May 09, 2025
Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort.

Xichun Hu, Qingyuan Zhang, Tao Sun

Pageof 3

Frequent Collaborators

4 joint publications

Jianli Ma

4 joint publications

Yuwei Deng

2 joint publications

Xiaojia Wang

2 joint publications

Binghe Xu